About this trial

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Eligibility criteria

Qualifiers

Ovarian tumor of low malignant potential

Low-grade serous carcinoma of the ovary

Primary peritoneal tumor of low malignant potential

Low-grade serous carcinoma of the peritoneum

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Biospecimen Collection
  • Electronic Health Record Review

Treatment groups

2,000 Participants
are divided into 1 treatment group

Locations

1
M D Anderson Cancer Center77030, HoustonTexas, United States

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor